Increased IGF-IEc expression and mechano-growth factor production in intestinal muscle of fibrostenotic Crohn's disease and smooth muscle hypertrophy.
Li. Chao C; Vu. Kent K; Hazelgrove. Krystina K; Kuemmerle. John F JF
Key Findings
- s disease patients",
- ,
Practical Outcomes
- MGF can promote smooth‑muscle growth beyond skeletal muscle, raising safety concerns for systemic use. Biohackers should be cautious about dosing and consider monitoring gut health, or prefer localized delivery methods to avoid unintended intestinal effects.
Summary
The study shows that a form of IGF‑1 called IGF‑IEc, which produces the peptide MGF, is higher in the gut muscle of people with a severe type of Crohn's disease and that this drives unwanted muscle thickening that can cause intestinal blockages. The same pathways that make muscle grow in the gut are activated by MGF, and blocking them stops the growth. For people experimenting with MGF for muscle building, this suggests a potential risk of causing similar unwanted smooth‑muscle growth elsewhere in the body, especially in the gut.
Abstract
The igf1 gene is alternatively spliced as IGF-IEa and IGF-IEc variants in humans. In fibrostenotic Crohn's disease, the fibrogenic cytokine TGF-β1 induces IGF-IEa expression and IGF-I production in intestinal smooth muscle and results in muscle hyperplasia and collagen I production that contribute to stricture formation. Mechano-growth factor (MGF) derived from IGF-IEc induces skeletal and cardiac muscle hypertrophy following stress. We hypothesized that increased IGF-IEc expression and MGF production mediated smooth muscle hypertrophy also characteristic of fibrostenotic Crohn's disease. IGF-IEc transcripts and MGF protein were increased in muscle cells isolated from fibrostenotic intestine under regulation by endogenous TGF-β1. Erk5 and MEF2C were phosphorylated in vivo in fibrostenotic muscle; both were phosphorylated and colocalized to nucleus in response to synthetic MGF in vitro. Smooth muscle-specific protein expression of α-smooth muscle actin, γ-smooth muscle actin, and smoothelin was increased in affected intestine. Erk5 inhibition or MEF2C siRNA blocked smooth muscle-specific gene expression and hypertrophy induced by synthetic MGF. Conditioned media of cultured fibrostenotic muscle induced muscle hypertrophy that was inhibited by immunoneutralization of endogenous MGF or pro-IGF-IEc. The results indicate that TGF-β1-dependent IGF-IEc expression and MGF production in patients with fibrostenotic Crohn's disease regulates smooth muscle cell hypertrophy a critical factor that contributes to intestinal stricture formation.
Study Information
pubmed
2015
2015-10-01T00:00:00.000Z
10.1152/ajpgi.00414.2014
15
39